Genius Group Ltd risk profile
87 Acute at or past the historical limit
Measured 1 September 2026 from GNS's filed statements. Recomputed nightly.
87 (Acute), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 82 | Acute | Volatile | One-year price volatility — 95.8% |
| Operating pressure | 77 | Stretched | Stable | Costs outgrowing revenue — +11.0 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.21x |
| Leverage and coverage | 96 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 87 | Acute | Stable | Operating-margin gap against peers — -314.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Genius Group Ltd